IRCT20230516058205N1已完成4 期
Evaluation of effect of spironolactone on proteinuria in kidney transplant patients
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Persons with more than three months after kidney transplantation
- •Proteinuria more than 0.5 gram per day
- •Estimated glomerular filtration rate more than 30 mili liter per minute
- •Consent to participate in study
排除标准
- •Serum potassium more than 5.5
- •Gynechomastia
- •Transplant dysfunction(eGFR<30)
- •Spironolactone usage for heart and liver failure
- •sensitivity to spironolactone
研究者
相似试验
进行中（未招募）
1 期
The protective effect of the drug spironolactone on transplanted kidneysEUCTR2011-002243-98-DKDepartment of Nephrology, OUH, Odense, DK170
已完成
2 期
The effect of spironolactone in treatment of heart failureHeart Failure.Congestive heart failureIRCT2015101924597N1Vice chancellor for research of Iran university of medical sciences60
已完成
不适用
The effects of spironolactone on endothelial function, autonomic function and glycaemic control in diabetic patients with poor blood pressure controlISRCTN76558770Tenovus Scotland (UK)50
已完成
不适用
combination therapy trial in COVID-19 patientsCOVID19.COVID-19, virus identifiedU07.1IRCT20201003048904N2Boushehr University of Medical Sciences200
Unknown
4 期
Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial HypertensionPulmonary HypertensionNCT01468571Baylor College of Medicine50